Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Airway Shield is a Spanish medtech company developing airway-management devices for safer endotracheal intubation. Its flagship product, Airway Shield, is a disposable guide-barrier mouthpiece designed to facilitate tube placement while protecting patients from dental and mucosal trauma and reducing clinician exposure to aerosols and droplets. The company positions the device as the first product of its kind to combine intubation guidance with barrier protection. Airway Shield has reported CE marking, FDA STeP designation, patent activity, and early human clinical evaluation, and appears to be pursuing international regulatory and commercial expansion. The company collaborates with hospitals and healthcare centers and is focused on critical care, anesthesia, emergency medicine, and related airway procedures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Airway Shield.